TY - JOUR
T1 - Integrating population variation and protein structural analysis to improve clinical interpretation of missense variation
T2 - application to the WD40 domain
AU - Laskowski, Roman A.
AU - Tyagi, Nidhi
AU - Johnson, Diana
AU - Joss, Shelagh
AU - Kinning, Esther
AU - McWilliam, Catherine
AU - Splitt, Miranda
AU - Thornton, Janet M.
AU - Firth, Helen V.
AU - Wright, Caroline F.
N1 - This work was supported by the Health Innovation Challenge
Fund (grant no. HICF-1009-003), a parallel funding partnership
between the Wellcome Trust and the Department of Health and
the Wellcome Trust Sanger Institute (grant no. WT098051). The
views expressed in this publication are those of the author(s)
and not necessarily those of the Wellcome Trust or the Department
of Health. The study has UK Research Ethics Committee approval
(10/H0305/83, granted by the Cambridge South REC, and
GEN/284/12, granted by the Republic of Ireland REC). Funding
to pay the Open Access publication charges for this article was
provided by the Wellcome Trust Sanger Institute.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - We present a generic, multidisciplinary approach for improving our understanding of novel missense variants in recently discovered disease genes exhibiting genetic heterogeneity, by combining clinical and population genetics with protein structural analysis. Using six new de novo missense diagnoses in TBL1XR1 fromthe Deciphering Developmental Disorders study, together with population variation data, we show that the β-propeller structure of the ubiquitous WD40 domain provides a convincing way to discriminate between pathogenic and benign variation. Children with likely pathogenic mutations in this gene have severely delayed language development, often accompanied by intellectual disability, autism, dysmorphology and gastrointestinal problems. Amino acids affected by likely pathogenic missense mutations are either crucial for the stability of the fold, forming part of a highly conserved symmetrically repeating hydrogen-bonded tetrad, or located at the top face of the β-propeller, where 'hotspot' residues affect the binding of β-catenin to the TBLR1 protein. In contrast, those altered by population variation are significantly less likely to be spatially clustered towards the top face or to be at buried or highly conserved residues. This result is useful not only for interpreting benign and pathogenic missense variants in this gene, but also in other WD40 domains, many of which are associated with disease.
AB - We present a generic, multidisciplinary approach for improving our understanding of novel missense variants in recently discovered disease genes exhibiting genetic heterogeneity, by combining clinical and population genetics with protein structural analysis. Using six new de novo missense diagnoses in TBL1XR1 fromthe Deciphering Developmental Disorders study, together with population variation data, we show that the β-propeller structure of the ubiquitous WD40 domain provides a convincing way to discriminate between pathogenic and benign variation. Children with likely pathogenic mutations in this gene have severely delayed language development, often accompanied by intellectual disability, autism, dysmorphology and gastrointestinal problems. Amino acids affected by likely pathogenic missense mutations are either crucial for the stability of the fold, forming part of a highly conserved symmetrically repeating hydrogen-bonded tetrad, or located at the top face of the β-propeller, where 'hotspot' residues affect the binding of β-catenin to the TBLR1 protein. In contrast, those altered by population variation are significantly less likely to be spatially clustered towards the top face or to be at buried or highly conserved residues. This result is useful not only for interpreting benign and pathogenic missense variants in this gene, but also in other WD40 domains, many of which are associated with disease.
U2 - 10.1093/hmg/ddv625
DO - 10.1093/hmg/ddv625
M3 - Article
C2 - 26740553
SN - 0964-6906
VL - 25
SP - 927
EP - 935
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 5
ER -